These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7421492)

  • 21. Sézary syndrome. A malignant leukemic reticuloendotheliosis.
    Tedeschi LG; Lansinger DT
    Arch Dermatol; 1965 Sep; 92(3):257-62. PubMed ID: 11851246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome.
    Michaelis S; Kazakov DV; Burg G; Dummer R; Kempf W
    Int J Dermatol; 2006 Mar; 45(3):277-9. PubMed ID: 16533228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine.
    Bouwhuis SA; el-Azhary RA; McEvoy MT; Gibson LE; Habermann TM; Witzig TE; Pittelkow MR
    Int J Dermatol; 2002 Jun; 41(6):352-6. PubMed ID: 12100691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Simultaneous occurrence of Sézary syndrome and B-cell chronic lymphocytic leukaemia].
    Parisi E; Clody P; Mazurier I; Grange F; Tortel MC; Moskovtchenko P
    Ann Biol Clin (Paris); 2003; 61(1):94-8. PubMed ID: 12604393
    [No Abstract]   [Full Text] [Related]  

  • 25. Neurolymphomatosis associated with Sézary syndrome.
    Bezier M; Reguiaï Z; Delaby P; Laroche L; Saïd G; Bernard P; Grange F
    Arch Dermatol; 2009 Mar; 145(3):294-6. PubMed ID: 19289760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of trauma-related coronary disease from the internist's viewpoint].
    Kababgi MD
    Lebensversicher Med; 1979 Jan; 31(1):11-3. PubMed ID: 32447
    [No Abstract]   [Full Text] [Related]  

  • 27. Large cell transformation of Sézary syndrome. A conventional and molecular cytogenetic study.
    So CC; Wong KF; Siu LL; Kwong YL
    Am J Clin Pathol; 2000 Jun; 113(6):792-7. PubMed ID: 10874879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sézary syndrome: The cause of erythema revealed by the blood film.
    Hinton R; Yebra-Fernandez E; Bain BJ
    Am J Hematol; 2019 Sep; 94(9):1042-1043. PubMed ID: 31257619
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
    Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
    Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers.
    Klemke CD; Brade J; Weckesser S; Sachse MM; Booken N; Neumaier M; Goerdt S; Nebe TC
    Br J Dermatol; 2008 Sep; 159(4):871-80. PubMed ID: 18652582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
    Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
    Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of high-risk human papillomaviruses in verrucae of patients with mycosis fungoides and Sézary syndrome: a case series.
    Vidulich KA; Rady PL; He Q; Tyring SK; Duvic M
    Int J Dermatol; 2009 Jun; 48(6):598-602. PubMed ID: 19538368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactive polyclonal T-cell lymphocytosis mimicking Sezary syndrome in a patient with hairy cell leukemia.
    Wulf GG; Schulz H; Hallermann C; Kunze E; Wörmann B
    Haematologica; 2001 Oct; 86(10):E27. PubMed ID: 11602434
    [No Abstract]   [Full Text] [Related]  

  • 34. Bexarotene monotherapy for patients with refractory Sézary syndrome.
    Staib G; Scharffetter-Kochanek K
    Dermatol Clin; 2008 Jan; 26 Suppl 1():61-3. PubMed ID: 18405190
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapy.
    Brennand S; Sutton VR; Biagi J; Trapani JA; Westerman D; McCormack CJ; Seymour JF; Kennedy G; Prince HM
    Br J Dermatol; 2005 Jun; 152(6):1199-205. PubMed ID: 15948982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant expression of T-plastin in Sezary cells.
    Su MW; Dorocicz I; Dragowska WH; Ho V; Li G; Voss N; Gascoyne R; Zhou Y
    Cancer Res; 2003 Nov; 63(21):7122-7. PubMed ID: 14612505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sezary lineage cells can be induced to proliferate via CD28-mediated costimulation.
    McCusker ME; Garifallou M; Bogen SA
    J Immunol; 1997 May; 158(10):4984-91. PubMed ID: 9144518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical characteristics of mycosis fungoides and Sézary syndrome].
    Krc L; Dobesová J; Bucek M; Dusek J; Macák J; Galuszková D; Jurysek O
    Vnitr Lek; 1997 May; 43(5):285-9. PubMed ID: 9601850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel and highly recurrent chromosomal alterations in Sézary syndrome.
    Vermeer MH; van Doorn R; Dijkman R; Mao X; Whittaker S; van Voorst Vader PC; Gerritsen MJ; Geerts ML; Gellrich S; Söderberg O; Leuchowius KJ; Landegren U; Out-Luiting JJ; Knijnenburg J; Ijszenga M; Szuhai K; Willemze R; Tensen CP
    Cancer Res; 2008 Apr; 68(8):2689-98. PubMed ID: 18413736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.